AQP1 and hepatopulmonary syndrome: In rats with hepatopulmonary syndrome, AQP1 enhanced pulmonary arterial smooth muscle cell (PASMC) migration via the p38 MAPK pathway, which may represent a potential therapeutic strategy for the regulation of pulmonary vascular remodelling [42].